CDKN1A and metabolic dysfunction-associated steatotic liver disease: A study comparing liver biopsies from normal controls and patients with NAFLD found that hepatocyte p21 expression was significantly associated with stage of fibrosis and clinical outcomes, such as the development of hepatocellular carcinoma, the need for liver transplantation and liver-related death [123].